Welcome to the website of BBMRI-LPC biobanks!BBMRI-LPC is a European-wide project involving 30 partners from 17 countries.The project represents the next phase of the successful EU biobanking programme BBMRI (Biobanking and Biomolecular Resources Research Infrastructure, www.bbmri.eu). The BBMRI Preparatory Phase was funded from 2007 to 2011. The European Research Infrastructure Consortium (BBMRI-ERIC) will become effective in the second half of 2013.In the past decades, European countries have invested millions of euros of funding and substantial amount of time for the establishment of large collections of volunteering individuals' biological samples and health-related information to be used in the research of human health and disease. These Large Prospective Cohort (LPC) studies recruit a random sample of participants from the general population and follow them for years or decades. These cohort studies provide important information on the early phases of the development of a large variety of diseases. However, they require large numbers of subjects, which in many cases can only be achieved by the joint effort of different cohorts from different countries.BBMRI-LPC is a four-year project. It has the aim to help scientists to have better access to large European studies on health (see press release on BBMRI-LPC).You can find more information on BBMRI-LPC here: bbmri-lpc.org.Currently there are 22 cohorts from all participating countries involved in the BBMRI-LPC-project.You can find an overview on every participating cohort here.Detailed information on the available samples and data of each cohort can be found in the catalogue of LPC-biobanks, which is a subcatalogue of the catalogue of European biobanks.
Background and Purpose:
BBMRI: The broader BBMRI initiative aims to establish a pan-European research infrastructure for biobanks and biomolecular resources, enhancing access to high-quality biological samples and associated data for researchers across Europe.
LPC Studies: These studies involve recruiting large numbers of participants from the general population and following them over years or decades to collect data and biological samples. They provide crucial insights into the early phases of various diseases and their development.
Objectives:
Facilitate Access: BBMRI-LPC aims to improve scientists' access to extensive European health studies by uniting different cohorts from various countries.
Enhance Research: By pooling resources and data, the project seeks to enable large-scale, high-impact research that individual cohorts might not achieve independently.
Key Features:
Duration: BBMRI-LPC is a four-year project.
Partnerships: The project involves 30 partners from 17 countries, reflecting a broad collaborative effort across Europe.
Cohorts: Currently, 22 cohorts from all participating countries are involved, providing a rich source of data and biological samples.
Infrastructure:
Catalogue of LPC-biobanks: This subcatalogue of the European biobanks catalogue offers detailed information on the available samples and data from each cohort. It serves as a comprehensive resource for researchers seeking specific types of samples and data for their studies.
Importance:
Investment: Over the past decades, European countries have invested significant funds and effort into establishing large biobanks and LPC studies. These investments underline the importance of biobanking for advancing human health research.
Collaborative Effort: The scale and success of LPC studies often require joint efforts across different cohorts and countries, exemplifying the collaborative nature of BBMRI-LPC.